Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: Lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study

Liesbeth C. de Wreede, Maggie Watson, Marleen van Os, Donald Milligan, Michel van Gelder, Mauricette Michallet, Peter Dreger, Claire E. Dearden, Janis Homewood, Jehan Dupuis, Michel Leporrier, Michal Karas, Bernadette Corront, Gabriela M. Baerlocher, Wolfgang Herr, Sylvain Choquet, Dietger W. Niederwieser, Laurent Sutton, Nicolaus Kroeger, Theo M. de WitteJohannes Schetelig

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)174-180
JournalAmerican Journal of Hematology
Volume89
Issue number2
DOIs
Publication statusPublished - Feb 2014

Cite this

de Wreede, L. C., Watson, M., van Os, M., Milligan, D., van Gelder, M., Michallet, M., Dreger, P., Dearden, C. E., Homewood, J., Dupuis, J., Leporrier, M., Karas, M., Corront, B., Baerlocher, G. M., Herr, W., Choquet, S., Niederwieser, D. W., Sutton, L., Kroeger, N., ... Schetelig, J. (2014). Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: Lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study. American Journal of Hematology, 89(2), 174-180. https://doi.org/10.1002/ajh.23610